Avilex Pharma develops novel inhibitors of PDZ domain proteins to target a range of unmet medical needs with a lead drug candidate AVLX-144 for the treatment of ischemic stroke.
If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact firstname.lastname@example.org or +45 5150 0560
Copyright 2015 Danskbiotek. All rights reserved.
created by: Mastafu Design